Anti-Obesity Medication Use in Commercially Insured Adults in the United States

被引：0
|
作者：
Kan, Hong
Sacks, Naomi
Chiu, Kevin
Shinde, Shraddha
Poon, Jiat Ling
Ahmad, Nadia
机构：
来源：
OBESITY | 2020年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
031
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [41] Multiple sclerosis prevalence in the United States commercially insured population
    Dilokthornsakul, Piyameth
    Valuck, Robert J.
    Nair, Kavita V.
    Corboy, John R.
    Allen, Richard R.
    Campbell, Jonathan D.
    [J]. NEUROLOGY, 2016, 86 (11) : 1014 - 1021
  • [42] Oral Glucocorticoid and Anti-osteoporosis Medication Use in Commercially Insured Americans (2001-2011)
    Overman, Robert A.
    Gourlay, Margaret L.
    Deal, Chad L.
    Farley, Joel F.
    Brookhart, M. Alan
    Layton, J. Bradley
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 18 - 19
  • [43] Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States
    Benedict, Kaitlin
    Beer, Karlyn D.
    Jackson, Brendan R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (06) : 1003 - 1010
  • [44] LONGITUDINAL RESOURCE USE FOR LOW BACK PAIN IN COMMERCIALLY-INSURED PATIENTS IN THE UNITED STATES
    Bresnahan, B. W.
    Rundell, S.
    Beck, S. J.
    Hansen, R. N.
    Jarvik, J. G.
    Sullivan, S. D.
    Flum, D.
    Alfonso-Cristancho, R.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A5 - A5
  • [45] Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
    Zhao, Danni
    Baek, Jonggyu
    Hume, Anne L.
    McPhillips, Emily A.
    Lapane, Kate L.
    [J]. JOURNAL OF PAIN RESEARCH, 2022, 15 : 443 - 454
  • [46] An algorithm for the use of anti-obesity medications
    Dehghani, Fereshteh
    Ahmadi, Mitra Ali
    Hefner, Marleigh
    Kudchadkar, Gaurav
    Najam, Wasiuddin
    Nateqi, Masoud
    Siddik, Md Abu Bakkar
    Booe, Holli
    Dhurandhar, Nikhil V.
    [J]. NUTRITION & DIABETES, 2024, 14 (01)
  • [47] Trends and Components of Thyroid Status Evaluation in Commercially Insured Adults in the United States, 2006-2020
    Morris, Earl J.
    Vouri, Scott M.
    Maraka, Spyridoula
    Ospina, Naykky Singh
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (03): : 611 - 618
  • [48] ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE AMONG COMMERCIALLY INSURED ADULTS DIAGNOSED WITH COLORECTAL CANCER IN THE UNITED STATES
    Davies-Teye, B. B.
    Slejko, J. F.
    Lee, T. Y.
    Onukwugha, E.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S91 - S91
  • [49] The Effective Use of Anti-obesity Medications
    Schmitz, Sarah H.
    Aronne, Louis J.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2023, 52 (04) : 661 - 680
  • [50] Coupling Continuing Education with EHR Analysis to Identify Drivers of Anti-Obesity Medication Use
    Robinson, Katie
    Frederick, Jennifer
    Thorofare, Ben Carson
    Esgro, Robert
    Higginbotham, Jessica
    [J]. OBESITY, 2023, 31 : 269 - 269
12345